How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
44
NRC Quote, Financials, Valuation and Earnings
Last price:
$21.90
Seasonality move
:
-2.95%
Day range:
$19.97 - $22.00
52-week range:
$9.76 - $22.79
Dividend yield:
2.56%
P/E ratio:
28.86x
P/S ratio:
3.33x
P/B ratio:
32.20x
Volume:
63.3K
Avg. volume:
77.1K
1-year change:
31.37%
Market cap:
$460.9M
Revenue:
$143.1M
EPS (TTM):
$0.70
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NRC
National Research Corp.
|
-- | -- | -- | -- | -- |
|
CERT
Certara, Inc.
|
$103.2M | $0.10 | 4.37% | 380.88% | $12.38 |
|
DRIO
DarioHealth Corp.
|
$5M | -$1.59 | -24.79% | -245.23% | $18.00 |
|
FORA
Forian, Inc.
|
$7.7M | $0.01 | 32.51% | 56.25% | $2.10 |
|
GDRX
GoodRx Holdings, Inc.
|
$193.3M | $0.09 | -3.87% | 227.11% | $4.56 |
|
SPOK
Spok Holdings, Inc.
|
$34.6M | $0.24 | 2.09% | 18.18% | $20.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NRC
National Research Corp.
|
$20.34 | -- | $460.9M | 28.86x | $0.16 | 2.56% | 3.33x |
|
CERT
Certara, Inc.
|
$8.30 | $12.38 | $1.3B | 122.96x | $0.00 | 0% | 3.22x |
|
DRIO
DarioHealth Corp.
|
$10.94 | $18.00 | $26.3M | -- | $0.00 | 0% | 6.07x |
|
FORA
Forian, Inc.
|
$2.11 | $2.10 | $65.6M | 49.00x | $0.00 | 0% | 2.34x |
|
GDRX
GoodRx Holdings, Inc.
|
$2.28 | $4.56 | $773.9M | 26.54x | $0.00 | 0% | 1.05x |
|
SPOK
Spok Holdings, Inc.
|
$13.77 | $20.00 | $283.6M | 17.21x | $0.31 | 9.08% | 2.05x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NRC
National Research Corp.
|
84.83% | 2.268 | 28.57% | 0.39x |
|
CERT
Certara, Inc.
|
22.36% | 0.446 | 15.74% | 1.94x |
|
DRIO
DarioHealth Corp.
|
29.69% | 1.483 | 75.99% | 3.72x |
|
FORA
Forian, Inc.
|
0.06% | 0.694 | 0.03% | 3.58x |
|
GDRX
GoodRx Holdings, Inc.
|
47.58% | 0.610 | 37.77% | 2.62x |
|
SPOK
Spok Holdings, Inc.
|
4.71% | 0.991 | 2.07% | 0.97x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NRC
National Research Corp.
|
$20M | $7.7M | 17.01% | 61.55% | 22.36% | $10.2M |
|
CERT
Certara, Inc.
|
$50.9M | $6.8M | 0.79% | 1.02% | 6.53% | $25.5M |
|
DRIO
DarioHealth Corp.
|
$3M | -$9.5M | -28.66% | -41.55% | -189.42% | -$7.4M |
|
FORA
Forian, Inc.
|
$4M | -$299.3K | -2.24% | -2.86% | -3.86% | -$439.7K |
|
GDRX
GoodRx Holdings, Inc.
|
$161.2M | $26.4M | 2.63% | 4.78% | 13.48% | $58M |
|
SPOK
Spok Holdings, Inc.
|
$20M | $4.5M | 10.33% | 10.88% | 13.38% | $7.6M |
National Research Corp. vs. Competitors
-
Which has Higher Returns NRC or CERT?
Certara, Inc. has a net margin of 11.54% compared to National Research Corp.'s net margin of 1.46%. National Research Corp.'s return on equity of 61.55% beat Certara, Inc.'s return on equity of 1.02%.
Company Gross Margin Earnings Per Share Invested Capital NRCNational Research Corp.57.82% $0.18 $94.4M CERTCertara, Inc.48.67% $0.01 $1.4B -
What do Analysts Say About NRC or CERT?
National Research Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Certara, Inc. has an analysts' consensus of $12.38 which suggests that it could grow by 49.1%. Given that Certara, Inc. has higher upside potential than National Research Corp., analysts believe Certara, Inc. is more attractive than National Research Corp..
Company Buy Ratings Hold Ratings Sell Ratings NRCNational Research Corp.0 0 0 CERTCertara, Inc.7 6 0 -
Is NRC or CERT More Risky?
National Research Corp. has a beta of 0.490, which suggesting that the stock is 50.981% less volatile than S&P 500. In comparison Certara, Inc. has a beta of 1.474, suggesting its more volatile than the S&P 500 by 47.354%.
-
Which is a Better Dividend Stock NRC or CERT?
National Research Corp. has a quarterly dividend of $0.16 per share corresponding to a yield of 2.56%. Certara, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Research Corp. pays 45.99% of its earnings as a dividend. Certara, Inc. pays out -- of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios NRC or CERT?
National Research Corp. quarterly revenues are $34.6M, which are smaller than Certara, Inc. quarterly revenues of $104.6M. National Research Corp.'s net income of $4M is higher than Certara, Inc.'s net income of $1.5M. Notably, National Research Corp.'s price-to-earnings ratio is 28.86x while Certara, Inc.'s PE ratio is 122.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Research Corp. is 3.33x versus 3.22x for Certara, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NRCNational Research Corp.3.33x 28.86x $34.6M $4M CERTCertara, Inc.3.22x 122.96x $104.6M $1.5M
-
Which has Higher Returns NRC or DRIO?
DarioHealth Corp. has a net margin of 11.54% compared to National Research Corp.'s net margin of -41.48%. National Research Corp.'s return on equity of 61.55% beat DarioHealth Corp.'s return on equity of -41.55%.
Company Gross Margin Earnings Per Share Invested Capital NRCNational Research Corp.57.82% $0.18 $94.4M DRIODarioHealth Corp.60.22% -$3.05 $106.6M -
What do Analysts Say About NRC or DRIO?
National Research Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand DarioHealth Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 64.53%. Given that DarioHealth Corp. has higher upside potential than National Research Corp., analysts believe DarioHealth Corp. is more attractive than National Research Corp..
Company Buy Ratings Hold Ratings Sell Ratings NRCNational Research Corp.0 0 0 DRIODarioHealth Corp.3 1 0 -
Is NRC or DRIO More Risky?
National Research Corp. has a beta of 0.490, which suggesting that the stock is 50.981% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.161, suggesting its more volatile than the S&P 500 by 16.051%.
-
Which is a Better Dividend Stock NRC or DRIO?
National Research Corp. has a quarterly dividend of $0.16 per share corresponding to a yield of 2.56%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Research Corp. pays 45.99% of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios NRC or DRIO?
National Research Corp. quarterly revenues are $34.6M, which are larger than DarioHealth Corp. quarterly revenues of $5M. National Research Corp.'s net income of $4M is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, National Research Corp.'s price-to-earnings ratio is 28.86x while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Research Corp. is 3.33x versus 6.07x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NRCNational Research Corp.3.33x 28.86x $34.6M $4M DRIODarioHealth Corp.6.07x -- $5M -$2.1M
-
Which has Higher Returns NRC or FORA?
Forian, Inc. has a net margin of 11.54% compared to National Research Corp.'s net margin of -1.95%. National Research Corp.'s return on equity of 61.55% beat Forian, Inc.'s return on equity of -2.86%.
Company Gross Margin Earnings Per Share Invested Capital NRCNational Research Corp.57.82% $0.18 $94.4M FORAForian, Inc.50.97% -$0.00 $31.1M -
What do Analysts Say About NRC or FORA?
National Research Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Forian, Inc. has an analysts' consensus of $2.10 which suggests that it could fall by -0.47%. Given that Forian, Inc. has higher upside potential than National Research Corp., analysts believe Forian, Inc. is more attractive than National Research Corp..
Company Buy Ratings Hold Ratings Sell Ratings NRCNational Research Corp.0 0 0 FORAForian, Inc.0 1 0 -
Is NRC or FORA More Risky?
National Research Corp. has a beta of 0.490, which suggesting that the stock is 50.981% less volatile than S&P 500. In comparison Forian, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock NRC or FORA?
National Research Corp. has a quarterly dividend of $0.16 per share corresponding to a yield of 2.56%. Forian, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Research Corp. pays 45.99% of its earnings as a dividend. Forian, Inc. pays out -- of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios NRC or FORA?
National Research Corp. quarterly revenues are $34.6M, which are larger than Forian, Inc. quarterly revenues of $7.8M. National Research Corp.'s net income of $4M is higher than Forian, Inc.'s net income of -$151.2K. Notably, National Research Corp.'s price-to-earnings ratio is 28.86x while Forian, Inc.'s PE ratio is 49.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Research Corp. is 3.33x versus 2.34x for Forian, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NRCNational Research Corp.3.33x 28.86x $34.6M $4M FORAForian, Inc.2.34x 49.00x $7.8M -$151.2K
-
Which has Higher Returns NRC or GDRX?
GoodRx Holdings, Inc. has a net margin of 11.54% compared to National Research Corp.'s net margin of 0.57%. National Research Corp.'s return on equity of 61.55% beat GoodRx Holdings, Inc.'s return on equity of 4.78%.
Company Gross Margin Earnings Per Share Invested Capital NRCNational Research Corp.57.82% $0.18 $94.4M GDRXGoodRx Holdings, Inc.82.22% $0.00 $1.1B -
What do Analysts Say About NRC or GDRX?
National Research Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand GoodRx Holdings, Inc. has an analysts' consensus of $4.56 which suggests that it could grow by 100.03%. Given that GoodRx Holdings, Inc. has higher upside potential than National Research Corp., analysts believe GoodRx Holdings, Inc. is more attractive than National Research Corp..
Company Buy Ratings Hold Ratings Sell Ratings NRCNational Research Corp.0 0 0 GDRXGoodRx Holdings, Inc.4 6 0 -
Is NRC or GDRX More Risky?
National Research Corp. has a beta of 0.490, which suggesting that the stock is 50.981% less volatile than S&P 500. In comparison GoodRx Holdings, Inc. has a beta of 1.497, suggesting its more volatile than the S&P 500 by 49.715%.
-
Which is a Better Dividend Stock NRC or GDRX?
National Research Corp. has a quarterly dividend of $0.16 per share corresponding to a yield of 2.56%. GoodRx Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. National Research Corp. pays 45.99% of its earnings as a dividend. GoodRx Holdings, Inc. pays out -- of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios NRC or GDRX?
National Research Corp. quarterly revenues are $34.6M, which are smaller than GoodRx Holdings, Inc. quarterly revenues of $196M. National Research Corp.'s net income of $4M is higher than GoodRx Holdings, Inc.'s net income of $1.1M. Notably, National Research Corp.'s price-to-earnings ratio is 28.86x while GoodRx Holdings, Inc.'s PE ratio is 26.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Research Corp. is 3.33x versus 1.05x for GoodRx Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NRCNational Research Corp.3.33x 28.86x $34.6M $4M GDRXGoodRx Holdings, Inc.1.05x 26.54x $196M $1.1M
-
Which has Higher Returns NRC or SPOK?
Spok Holdings, Inc. has a net margin of 11.54% compared to National Research Corp.'s net margin of 9.46%. National Research Corp.'s return on equity of 61.55% beat Spok Holdings, Inc.'s return on equity of 10.88%.
Company Gross Margin Earnings Per Share Invested Capital NRCNational Research Corp.57.82% $0.18 $94.4M SPOKSpok Holdings, Inc.58.95% $0.15 $156.1M -
What do Analysts Say About NRC or SPOK?
National Research Corp. has a consensus price target of --, signalling downside risk potential of --. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 52.51%. Given that Spok Holdings, Inc. has higher upside potential than National Research Corp., analysts believe Spok Holdings, Inc. is more attractive than National Research Corp..
Company Buy Ratings Hold Ratings Sell Ratings NRCNational Research Corp.0 0 0 SPOKSpok Holdings, Inc.1 0 0 -
Is NRC or SPOK More Risky?
National Research Corp. has a beta of 0.490, which suggesting that the stock is 50.981% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.415, suggesting its less volatile than the S&P 500 by 58.512%.
-
Which is a Better Dividend Stock NRC or SPOK?
National Research Corp. has a quarterly dividend of $0.16 per share corresponding to a yield of 2.56%. Spok Holdings, Inc. offers a yield of 9.08% to investors and pays a quarterly dividend of $0.31 per share. National Research Corp. pays 45.99% of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Spok Holdings, Inc.'s is not.
-
Which has Better Financial Ratios NRC or SPOK?
National Research Corp. quarterly revenues are $34.6M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. National Research Corp.'s net income of $4M is higher than Spok Holdings, Inc.'s net income of $3.2M. Notably, National Research Corp.'s price-to-earnings ratio is 28.86x while Spok Holdings, Inc.'s PE ratio is 17.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for National Research Corp. is 3.33x versus 2.05x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NRCNational Research Corp.3.33x 28.86x $34.6M $4M SPOKSpok Holdings, Inc.2.05x 17.21x $33.9M $3.2M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 43x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 43x
Alerts
Sell
28
PFSI alert for Feb 3
PennyMac Financial Services, Inc. [PFSI] is down 6.76% over the past day.
Sell
40
SHNY alert for Feb 3
MicroSectors Gold 3X Leveraged ETN [SHNY] is down 11.85% over the past day.
Buy
60
RHI alert for Feb 3
Robert Half, Inc. [RHI] is down 1.73% over the past day.
